Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 2, Pages 406-411
Publisher
Oxford University Press (OUP)
Online
2012-10-07
DOI
10.1093/annonc/mds343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II randomized trial on dose-escalated sorafenib (S) versus best supportive care (BSC) in patients with advanced hepatocellular carcinoma (HCC) with disease progression on prior S treatment.
- (2017) T. Pressiani et al. JOURNAL OF CLINICAL ONCOLOGY
- Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) second interim analysis in more than 1,500 patients: Clinical findings in patients with liver dysfunction.
- (2017) J. A. Marrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score
- (2011) A. Hollebecque et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
- (2011) Jeong Eun Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
- (2011) Massimo Iavarone et al. HEPATOLOGY
- Sorafenib in clinical practice: Evidence-based use or abuse?
- (2011) Michele Basso et al. HEPATOLOGY
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma
- (2010) Markus Peck-Radosavljevic et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial
- (2009) Lorenza Rimassa et al. Expert Review of Anticancer Therapy
- Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
- (2009) Marcus Alexander Wörns et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
- (2009) Antonius A. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
- (2009) Puneeta Tandon et al. LIVER INTERNATIONAL
- Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis
- (2009) M. Pinter et al. ONCOLOGIST
- Sorafenib
- (2008) Dene Simpson et al. DRUGS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search